Active, Not Recruiting
Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy
NCT06680622
- Conditions
- Metastatic Gastro-esophageal Adenocarcinoma
- Locations
-
- Uniklinik RWTH Aachen Aachen, Germany
- Klinikum St. Marien Amberg, Germany
- Universitätsklinikum Augsburg Augsburg, Germany
- Helios Klinikum Bad Saarow Bad Saarow, Germany